サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1391202

エピジェネティクスの世界市場レポート 2024年

Epigenetics Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
エピジェネティクスの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

エピジェネティクスの市場規模は近年急激に拡大しています。2023年の90億米ドルから2024年には109億1,000万米ドルに、CAGR21.2％で拡大します。実績期間の成長は、研究費の増加、慢性疾患の罹患率の上昇、個別化医療の出現、がんの広範な研究、人口の高齢化に起因しています。

2023年のエピジェネティクス市場では北米が最大地域です。アジア太平洋は、予測期間中にエピジェネティクス市場で最も急成長する地域となる見込みです。エピジェネティクス世界市場分析レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 エピジェネティクス市場の特徴

第3章 エピジェネティクス市場の動向と戦略

第4章 エピジェネティクス市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界のエピジェネティクス市場規模と成長

  • 世界のエピジェネティクス市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界のエピジェネティクス市場規模の実績と成長、2018年から2023年
  • 世界のエピジェネティクス市場規模と成長予測、2023～2028年、2033F

第6章 エピジェネティクス市場セグメンテーション

  • 世界のエピジェネティクス市場、製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 試薬
  • 酵素
  • 器械
  • キット
  • 世界のエピジェネティクス市場、技術別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • DNAメチル化
  • ヒストンのメチル化
  • ヒストンのアセチル化
  • 大きな非コードRNA
  • マイクロRNA修飾
  • クロマチンの構造
  • 世界のエピジェネティクス市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 腫瘍学
  • 代謝性疾患
  • 発生生物学
  • 免疫学
  • 心血管疾患
  • その他の用途
  • 世界のエピジェネティクス市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 学術調査機関
  • 製薬会社およびバイオテクノロジー会社
  • 受託調査機関
  • その他のエンドユーザー

第7章 エピジェネティクス市場の地域および国分析

  • 世界のエピジェネティクス市場、地域別、実績および予測、2018-2023、2023-2028F、2033F
  • 世界のエピジェネティクス市場、国別、実績および予測、2018年から2023年、2023年から2028年まで、2033年まで

第8章 アジア太平洋エピジェネティクス市場

  • 概要
  • 地域情報、COVID-19の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国のエピジェネティクス市場

第10章 インドのエピジェネティクス市場

第11章 日本のエピジェネティクス市場

第12章 オーストラリアのエピジェネティクス市場

第13章 インドネシアのエピジェネティクス市場

第14章 韓国のエピジェネティクス市場

第15章 西欧のエピジェネティクス市場

  • 概要
  • 製品別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国のエピジェネティクス市場

第17章 ドイツのエピジェネティクス市場

第18章 フランスのエピジェネティクス市場

第19章 イタリアのエピジェネティクス市場

第20章 スペインのエピジェネティクス市場

第21章 東欧のエピジェネティクス市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアのエピジェネティクス市場

第23章 北米のエピジェネティクス市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国のエピジェネティクス市場

第25章 カナダのエピジェネティクス市場

第26章 南米のエピジェネティクス市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルのエピジェネティクス市場

第28章 中東のエピジェネティクス市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカのエピジェネティクス市場

  • 概要
  • 製品別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • 用途別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
  • エンドユーザー別のセグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 エピジェネティクス市場の競合情勢と企業プロファイル

  • エピジェネティクス市場の競合情勢
  • エピジェネティクス市場の企業プロファイル
    • Illumina Inc.
    • Thermo Fisher Scientific
    • Merck Millipore
    • Abcam
    • Active Motif

第31章 世界のエピジェネティクス市場の競合ベンチマーキング

第32章 世界のエピジェネティクス市場競争ダッシュボード

第33章 エピジェネティクス市場における主要な合併と買収

第34章 エピジェネティクス市場の将来展望と潜在力分析

第35章 付録

目次
Product Code: r9562

“Epigenetics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epigenetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for epigenetics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The epigenetics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Reagents; Enzymes; Instruments; Kits
  • 2) By Technology: DNA Methylation; Histone Methylation; Histone Acetylation; Large Noncoding RNA; MicroRNA Modification; Chromatin Structures
  • 3) By Application: Oncology; Metabolic Diseases; Developmental Biology; Immunology; Cardiovascular Diseases; Other Applications
  • 4) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Other End Users
  • Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific; Merck Millipore; Abcam; Active Motif
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Epigenetics refers to changes in gene activity transmitted to younger cells without modifying the DNA sequence. These natural and necessary processes are vital for the functioning of many organisms, but anomalies can lead to disorders such as various types of cancer, reproductive illnesses, and cardiovascular diseases. Epigenetics plays a crucial role in the early detection of certain cancers.

The primary products employed in the epigenetics market include reagents, enzymes, instruments, and kits. Reagents are compounds or substances used for chemical analysis or epigenetic testing. Technologies utilized in epigenetics encompass DNA methylation, histone methylation, histone acetylation, large noncoding RNA, microRNA modification, and chromatin structures. Applications span oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other fields. Epigenetic tools find applications in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and various other end-user segments.

The epigenetics market research report is one of a series of new reports from The Business Research Company that provides epigenetics market statistics, including epigenetics industry global market size, regional shares, competitors with an epigenetics market share, detailed epigenetics market segments, market trends and opportunities, and any further data you may need to thrive in the epigenetics industry. This epigenetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epigenetics market size has grown exponentially in recent years. It will grow from $9 billion in 2023 to $10.91 billion in 2024 at a compound annual growth rate (CAGR) of 21.2%. The growth in the historic period can be attributed to increased research funding, a rise in the incidence of chronic diseases, the emergence of personalized medicine, extensive research in cancer, and an aging population.

The epigenetics market size is expected to see exponential growth in the next few years. It will grow to $23.86 billion in 2028 at a compound annual growth rate (CAGR) of 21.6%. The growth in the forecast period can be attributed to developments in epigenetic drug development, increased focus on epigenetics in environmental health, applications of epigenetics in precision agriculture, regulatory support, and growing awareness and advocacy among patients. Major trends in the forecast period include advancements in epitranscriptomics, single-cell epigenomics, the emergence of epigenetic editing, utilization of epigenetic biomarkers, increased research in aging and longevity, and exploration of microbiome-epigenome interactions.

The growth of the epigenetics market is significantly influenced by the increasing prevalence of cancer and other diseases. The rising incidence of diseases, such as cancer, drives the demand for epigenetic testing and analysis. For instance, a report from the European Commission's Joint Research Centre in September 2021 projected a 21.4% increase in new cancer cases in the European Union and European Free Trade Association countries from 2.8 million in 2020 to 3.4 million in 2040. Additionally, data from the Centers for Disease Control and Prevention (CDC) indicated that approximately 659,000 people in the United States die from heart disease each year. The need for understanding genetic modifications in diseases like cancer enhances the usage and demand for epigenetics. Consequently, the growing prevalence of cancer and other diseases is a major driver fueling the epigenetics market.

The epigenetics market is expected to experience growth due to the increasing focus on precision medicine. Precision medicine involves tailoring medical approaches based on an individual's genetic, environmental, and lifestyle information for more effective disease management and treatment. In the realm of epigenetics, precision medicine utilizes individual epigenetic profiles and genetic data to formulate personalized healthcare strategies. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research approved 37 new molecular entities, with 34% of therapeutic new molecular entities classified as personalized medicines, according to the Personalized Medicine Coalition. This emphasis on precision medicine is contributing to the expansion of the epigenetics market.

A key trend in the epigenetics market is technological advancement. Major players in the epigenetics sector are dedicated to developing advanced products and services, leveraging cutting-edge technologies to enhance their market positions. For instance, Givaudan Active Beauty, a Switzerland-based company, launched Chronoglow in May 2021. Chronoglow is a skin-care-beneficial active component created through green fractionation and supported by artificial intelligence (AI). It replicates natural epigenetic mechanisms and is derived from the resurrection plant, Haberlea rhodopensis. Chronoglow acts as a natural skin remedy, improving skin luminosity and reversing signs of aging. The trend of technological advancement is shaping the landscape of the epigenetics market.

Leading companies in the epigenetics market are increasingly incorporating artificial intelligence (AI)-driven analytics into their operations to gain a competitive advantage. AI-driven analytics involves utilizing artificial intelligence technologies to automatically analyze and interpret large volumes of data. For example, in July 2023, FOXO Technologies, a US-based company, introduced Bioinformatics Services aimed at revolutionizing epigenetic data analysis. These services offer a versatile platform with advanced data solutions tailored to meet the specific needs of clients in academia, healthcare, and pharmaceutical research. FOXO's innovative suite of bioinformatic tools aims to enhance the speed and accuracy of data processing, analysis, and interpretation, facilitating quicker discoveries and advancing understanding of complex diseases.

In a strategic move, Chroma Medicine Inc., a prominent biotechnology company based in the United States, acquired Epsilen Bio for $125 billion in November 2021. This acquisition is expected to play a crucial role in expanding Chroma Medicine Inc.'s epigenetic editing platform and reinforcing its position in the market. Epsilen Bio, headquartered in Italy, specializes in developing transformative therapies through targeted epigenetic silencing of genes. This acquisition aligns with the broader industry trend of companies investing in technologies and capabilities to drive advancements in the field of epigenetics.

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Abcam, Active Motif, Abcam PLC, Active Motiff, Hologic Inc., Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Cytosine Therapeutics, Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline PLC, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx PLC, Zymeworks Inc.

North America was the largest region in the epigenetics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the global epigenetics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the epigenetics market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The epigenetics market includes revenues earned by entities methylation, acetylation, phosphorylation, ubiquitylation, and sumolyation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Epigenetics Market Characteristics

3. Epigenetics Market Trends And Strategies

4. Epigenetics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Epigenetics Market Size and Growth

  • 5.1. Global Epigenetics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Epigenetics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Epigenetics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Epigenetics Market Segmentation

  • 6.1. Global Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagents
  • Enzymes
  • Instruments
  • Kits
  • 6.2. Global Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Noncoding RNA
  • MicroRNA Modification
  • Chromatin Structures
  • 6.3. Global Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Metabolic Diseases
  • Developmental Biology
  • Immunology
  • Cardiovascular Diseases
  • Other Applications
  • 6.4. Global Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Contract Research Organizations
  • Other End Users

7. Epigenetics Market Regional And Country Analysis

  • 7.1. Global Epigenetics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Epigenetics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Epigenetics Market

  • 8.1. Asia-Pacific Epigenetics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Epigenetics Market

  • 9.1. China Epigenetics Market Overview
  • 9.2. China Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Epigenetics Market

  • 10.1. India Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Epigenetics Market

  • 11.1. Japan Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Epigenetics Market

  • 12.1. Australia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Epigenetics Market

  • 13.1. Indonesia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Epigenetics Market

  • 14.1. South Korea Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Epigenetics Market

  • 15.1. Western Europe Epigenetics Market Overview
  • 15.2. Western Europe Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Epigenetics Market

  • 16.1. UK Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Epigenetics Market

  • 17.1. Germany Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Epigenetics Market

  • 18.5. France Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Epigenetics Market

  • 19.9. Italy Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Epigenetics Market

  • 20.13. Spain Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Epigenetics Market

  • 21.1. Eastern Europe Epigenetics Market Overview
  • 21.2. Eastern Europe Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Epigenetics Market

  • 22.1. Russia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Epigenetics Market

  • 23.1. North America Epigenetics Market Overview
  • 23.2. North America Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Epigenetics Market

  • 24.1. USA Epigenetics Market Overview
  • 24.2. USA Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Epigenetics Market

  • 25.1. Canada Epigenetics Market Overview
  • 25.2. Canada Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Epigenetics Market

  • 26.1. South America Epigenetics Market Overview
  • 26.2. South America Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Epigenetics Market

  • 27.1. Brazil Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Epigenetics Market

  • 28.1. Middle East Epigenetics Market Overview
  • 28.2. Middle East Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Epigenetics Market

  • 29.1. Africa Epigenetics Market Overview
  • 29.2. Africa Epigenetics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Epigenetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Epigenetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Epigenetics Market Competitive Landscape And Company Profiles

  • 30.1. Epigenetics Market Competitive Landscape
  • 30.2. Epigenetics Market Company Profiles
    • 30.2.1. Illumina Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck Millipore
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abcam
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Active Motif
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Epigenetics Market Competitive Benchmarking

32. Global Epigenetics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Epigenetics Market

34. Epigenetics Market Future Outlook and Potential Analysis

  • 34.1 Epigenetics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Epigenetics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Epigenetics Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer